Navigation Links
FDA Warnings on Mercury Tooth Fillings Expected Today: New Regulation Result of Lawsuit Settled Last Year
Date:7/28/2009

WASHINGTON, July 28 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration is expected to issue a new regulation today calling for special controls on the placement of mercury tooth fillings. Until now, dentists who used amalgam have not had to disclose the type of materials used in dental fillings or advise patients, and particularly sensitive populations, of its use.

The ruling results from a lawsuit settled last year by the plaintiffs in the case of Moms Against Mercury v. Von Eschenbach. The settlement required FDA to withdraw claims of amalgam's safety from its web site and reclassify its use by July 28, 2009.

"After 32 years of delays, FDA finally warned Americans about neurotoxic effects from amalgam to the nervous systems of developing children and fetus," said Michael Bender, a plaintiff in the lawsuit and director of the Mercury Policy Project. "This breakthrough corresponds to the one in 2004 when FDA first warned pregnant women and children to limit consumption of certain tuna."

As reflected in the May 2008 court transcripts, Judge Ellen Huvelle stated that the "...probability of harm is enormous," and asked the FDA: "How could you drag your feet for 32 years? Do what you are supposed to do." Judge Huvelle also said that she couldn't ". . .order a ban, but can compel to act," observing that this was "government at its worst" and that she wanted this "public safety issue to be resolved." (See link to court transcript at the end of release.)

As part of the settlement, FDA agreed to change its website -- dramatically. In addition to recognizing that amalgam contains a neurotoxin that may present a risk to children, the FDA website now says, for example, that: "Some other countries follow a "precautionary principle" and avoid the use of dental amalgam in pregnant women."

These warnings are similar to those from manufacturers. Amalgam arrives at a dentist's office with skull and cross bones affixed next to the words "POISON, CONTAINS METALLIC MERCURY." Manufacturers advise dentists against placing amalgam in pregnant women, nursing mothers, children under six, and anyone with kidney disease. For example, Dentsply has warned: "Contraindication In children 6 and under" and "In expectant mothers."

However, most Americans are not aware of these warnings, according to a poll conducted for the Mercury Policy Project by Zogby International. The poll indicates that most Americans (76%) don't know mercury is the primary component of amalgam, but when informed, almost all (92%) want to be informed prior to treatment. The poll also found that most Americans (77%) would choose higher cost mercury-free fillings -- given the choice -- and a large majority (69%) support a ban on placement of mercury fillings in pregnant women and children.

More information:

May 16, 2008 court transcripts:

http://mpp.cclearn.org/wp-content/uploads/2008/08/transcript051508momsvfda.pdf

FDA website:

http://tinyurl.com/mm3etn

Dentsply's warning:

http://mpp.cclearn.org/wp-content/uploads/2008/08/dispersalloycontraindication1997.pdf

Results of Zogby poll:

http://mpp.cclearn.org/wp-content/uploads/2008/08/whatpatientsdontknow.pdf

June 10, 2008 Mercury Policy web post:

www.mercurypolicy.org


'/>"/>
SOURCE Mercury Policy Project
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. FDA Mandates Tougher Warnings for Pain Pills
2. NAM Launches Emergency Network System to Deliver Disaster Alerts and Health Warnings to Millions in Ethnic Communities
3. Depression Treatment Wanes Following FDA Warnings
4. More Dire Warnings for Social Security
5. FDA Mandates New Warnings for Botox
6. FDA Adds New Label Warnings to Over-the-Counter Painkillers
7. Docs Override Most Electronic Drug Warnings
8. TransMedia Group Retained by Renowned Plastic Surgeon Dr. Jeffrey Lagrasso to Share Beauty Trends, Warnings and Medical Perspective Previously Limited to the Rich and Famous
9. Treadmill Desks: A Healthy Alternative on the Heels of FDA Warnings of 25 Weight Loss Products
10. Leahy Slams Midnight Bid to Relax Mercury-in-Fish Warnings to Women and Children
11. Wrinkle Fillers Need Better Label Warnings: FDA Panel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 29, 2017 , ... The assembly of synthetic ... involve many repetitive steps and often scientists require many different versions of DNA. ... and results in a lower error rate and cost saving for reagents and ...
(Date:3/29/2017)... , ... March 29, 2017 ... ... and South Hills of Pittsburgh now have easier access to the robotic-assisted ... by Allegheny Health Network (AHN). Orthopaedic surgeons at Forbes Hospital and Jefferson ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... AvePoint ... seventh North American office location in Richmond, Virginia, located at the Riverfront Plaza, 901 ... attended by Lieutenant Governor of Virginia Ralph S. Northam and Mayor of Richmond Levar ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... Tuesday, March ... the American public to take the Diabetes Risk Test to find out if they ... Los Angeles World Airports will light up the evening sky by programming the LAX ...
(Date:3/28/2017)... ... March 28, 2017 , ... Greenfield ... Williamson brings his extensive knowledge of appraisals, property values, ad valorem taxation, and ... estate valuation industry for more than 40 years. , “Ruel is a great ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , March 29, 2017  Spiral Therapeutics, ... agreement with Bionure Farma, S.L. for the worldwide ... to BN119 in the field of otolaryngology for ... sales-based royalties. The agreement provides Spiral with ... with a differentiated product profile. Under the terms ...
(Date:3/29/2017)... HEIGHTS, Utah , March 29, 2017 /PRNewswire/ ... ) announced today the appointment of Cynthia ... Operations.  Cyndi will be responsible for leading Dynatronics ... organization and will report to Dynatronics, CEO ... Cyndi,s appointment concludes an extensive search process conducted ...
(Date:3/29/2017)... SPRING, Md. , March 29, 2017 On March ... (ocrelizumab) to treat adult patients with relapsing forms of ... This is the first drug approved by the FDA ... a health care professional.  "Multiple sclerosis ... said Billy Dunn , M.D., director of the ...
Breaking Medicine Technology: